Martin MacKay

Martin MacKay

Founder chez RALLYBIO CORPORATION

Fortune : 5 M $ au 29/02/2024

68 ans
Health Technology
Commercial Services
Technology Services

Profil

Martin W.
MacKay
is an American businessperson who founded Rallybio Corp.
and Rallybio LLC and who has been the head of 8 different companies.
Presently, Dr. MacKay is Executive Chairman for Rallybio Corp., Chairman & Chief Executive Officer for Rallybio LLC and Chief Executive Officer & Director at Rallybio Holdings LLC (both are subsidiaries of Rallybio Corp.) and Chief Executive Officer of Calyx Group Ltd.
(Ireland).
He is also on the board of Charles River Laboratories International, Inc., Charles River Laboratories, Inc. and Novo Nordisk A.
In his past career Dr. MacKay held the position of Chief Executive Officer & Director at Neverfail, Inc. and Chief Executive Officer & Director at Neverfail Ltd.
(a subsidiary of Neverfail, Inc.), Senior Vice President-Worldwide Development at Pfizer Inc. and President at Pfizer (St. Louis) (a subsidiary of Pfizer Inc.), President-Research & Development at AstraZeneca PLC and Global Head-Research & Development at Alexion Pharmaceuticals, Inc. (a subsidiary of AstraZeneca PLC), Vice President-International at VeriSign, Inc., Principal at PeopleSoft USA, Inc., Principal at Beecham Pharmaceuticals (UK), Senior Advisor at New Leaf Venture Partners LLC, Chief Executive Officer for Vecta Software Corp.
Ltd., Operations Director for The Dun & Bradstreet Corp., Head-Drug Preformulation & Delivery at BASF Performance Products Ltd.
(United Kingdom), Head-Molecular & Cell Biology at CRI Worldwide LLC, Principal at Accenture LLC, Director-Business Development at NorthgateArinso, Inc. and Head-Drug Preformulation & Delivery at Ciba-Geigy Pharmaceuticals.
He received an undergraduate degree from Heriot-Watt University and a doctorate from The University of Edinburgh.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
03/07/2023 11 600 ( 0,02% ) 3 M $ 29/02/2024
15/02/2024 719 126 ( 1,90% ) 2 M $ 29/02/2024

Postes actifs de Martin MacKay

SociétésPosteDébut
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Director/Board Member 05/07/2017
NOVO NORDISK A/S Director/Board Member 01/03/2018
RALLYBIO CORPORATION Founder 01/01/2018
Director/Board Member -
Chief Executive Officer -
Chief Executive Officer 01/01/2018
Chief Executive Officer 22/12/2010
Tous les postes actifs de Martin MacKay

Anciens postes connus de Martin MacKay

SociétésPosteFin
501 ACQU Director/Board Member 22/04/2022
ALEXION PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 01/06/2017
░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ -
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Martin MacKay

Formation de Martin MacKay

The University of Edinburgh Doctorate Degree
Heriot-Watt University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Martin MacKay

Relations

99

Relations au 1er degré

28

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées6
PFIZER, INC.

Health Technology

ASTRAZENECA PLC

Health Technology

VERISIGN. INC.

Technology Services

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Commercial Services

NOVO NORDISK A/S

Health Technology

RALLYBIO CORPORATION

Health Technology

Entreprise privées20

Health Technology

Health Technology

Technology Services

Commercial Services

Communications

Process Industries

Technology Services

Finance

Health Technology

Commercial Services

Commercial Services

Technology Services

Commercial Services

Technology Services

Commercial Services

Ciba-Geigy Pharmaceuticals

Beecham Pharmaceuticals (UK)

Commercial Services

Health Services

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Martin MacKay